
NSF Org: |
CBET Division of Chemical, Bioengineering, Environmental, and Transport Systems |
Recipient: |
|
Initial Amendment Date: | March 5, 2018 |
Latest Amendment Date: | August 19, 2019 |
Award Number: | 1749382 |
Award Instrument: | Standard Grant |
Program Manager: |
Ron Joslin
rjoslin@nsf.gov (703)292-7030 CBET Division of Chemical, Bioengineering, Environmental, and Transport Systems ENG Directorate for Engineering |
Start Date: | March 15, 2018 |
End Date: | August 31, 2024 (Estimated) |
Total Intended Award Amount: | $503,244.00 |
Total Awarded Amount to Date: | $550,535.00 |
Funds Obligated to Date: |
FY 2019 = $47,291.00 |
History of Investigator: |
|
Recipient Sponsored Research Office: |
2500 BROADWAY LUBBOCK TX US 79409 (806)742-3884 |
Sponsor Congressional District: |
|
Primary Place of Performance: |
TX US 79409-3121 |
Primary Place of
Performance Congressional District: |
|
Unique Entity Identifier (UEI): |
|
Parent UEI: |
|
NSF Program(s): |
FD-Fluid Dynamics, GOALI-Grnt Opp Acad Lia wIndus |
Primary Program Source: |
01001920DB NSF RESEARCH & RELATED ACTIVIT |
Program Reference Code(s): |
|
Program Element Code(s): |
|
Award Agency Code: | 4900 |
Fund Agency Code: | 4900 |
Assistance Listing Number(s): | 47.041 |
ABSTRACT
Innovative DNA-based vaccines are currently under development and aim to revolutionize the fight against diseases such as cancer, HIV, Ebola and Zika. However, these vaccines must be delivered into the intradermal region of the skin, which is known to promote an enhanced immune response. Such a precise, consistent delivery of these drugs, which can be quite viscous, has not yet been achieved. One potential method to resolve this issue is needle-free jet injection, whereby liquid is forced out of a narrow orifice at high-speed and punctures the skin. This technique has been routinely applied for deeper (subcutaneous and intramuscular) injections, but now holds promise for intradermal delivery as well. Therefore, the principal aim of this project is to provide a deep understanding of the key factors governing intradermal injection with liquid jets. The project will also encompass significant educational activities, including a multi-year undergraduate research program, industry-based training and an outreach program for the local homeschool community.
The goal of this project is to develop a comprehensive picture of needle-free jet injection into intradermal regions of the skin. This complex process involves creation of a high-speed, slender and coherent jet, which impacts and punctures the skin and then disperses in a poro-elastic heterogeneous matrix of tissue. None of these features have been adequately assessed, either experimentally or theoretically. We propose to fill this broad knowledge gap with the combination of a rigorous experimental campaign and theoretical treatment focused in three specific aims: (i) Understanding the role of rheology in jet characteristics, (ii) Defining the criteria for maintaining jet coherency, and (iii) Determining the factors limiting fluid accumulation in the intradermal region. On the experimental side, we will use high-speed video tracking and dynamic force measurements to characterize the jet start-up, steady-stream speed and peak force for a variety of configurations and fluids. We will also perform both ex-vivo and in-vitro injection studies to examine the accumulation of fluid in the intradermal region. On the modeling front, we will focus on stability and coherence of the jet as a function of geometry prior to the orifice and fluid properties. Our approach is expected to yield unprecedented understanding and provide the platform for future innovation in needle-free injection.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH
Note:
When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external
site maintained by the publisher. Some full text articles may not yet be available without a
charge during the embargo (administrative interval).
Some links on this page may take you to non-federal websites. Their policies may differ from
this site.
PROJECT OUTCOMES REPORT
Disclaimer
This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.
Intellectual Merit:
The overarching goal of this project was to study the fluid dynamics of needle-free intradermal jet injection, which is an alternative method to deliver drugs to the skin without using standard hypodermic needles. The original motivation for this project stems from a confluence of needle-phobia, accidental needle-stick injuries, and poor outcomes in terms of immune response for novel nucleic acid vaccines delivered by needles. The specific aims of the project were: (1) Understand the role of fluid rheology in jet characteristics; (2) Define the criteria for maintaining jet coherency; (3) Determine the factors limiting bleb growth and maximum size. The most significant findings under these guiding aims are as follows:
- High viscosity drugs can be delivered. For spring-powered jet injectors, the hydrodynamic performance was characterized as a function of fluid viscosity, and we determined that even high-viscosity fluids can be delivered effectively with jet injectors. This is particularly important for a range of biologic drugs such as high-concentration DNA vaccines that have high viscosity.
- Higher viscosity fluids lead to more slender, collimated jet streams. whilst low viscosity water-like fluids result in dispersed turbulent jets. However, the stream collimation is not the only factor that determines whether an injection is successful; there is a confluence of spring force, fluid viscosity, and stand-off distance between the injector and the patient skin.
- The force with which an injector is pressed against the skin is a key variable. The load (force used to push into the skin) determines the efficiency of an injection; It was found that a range of approximately 5-10 N provides optimal injection efficiency (i.e. how much drug gets correctly deposited below the skin).
- Smooth contraction geometries are optimal. Using computational fluid dynamics (CFD) simulations, we studied the effect of geometry. Specifically, the tapering region from the main cartridge barrel to the orifice is important, and a smooth hyperbolic contraction was found to yield acceptable jet speeds with the lowest driving force.
- Parameters to optimize percentage delivery were found. Through extensive investigations using excised skin tissue (guinea pig, pig, human), we determined injection efficiencies for a range of configurations and elucidated the most important factors for increasing drug delivery to the skin. It was found that: (i) zero stand-off should be used (i.e., the device must be pressed directly against the skin), (ii) the device should be oriented perpendicular to the skin (i.e. at 90-degrees), (iii) an attachment to induce a wide contact area can improve lateral dispersion within the dermal tissues.
- Dual-depth injections are possible. We showed that a dual-orifice injector could facilitate simultaneous delivery to both intradermal (skin) and intramuscular (muscle) tissue, by using a custom-design ampoule with one narrow and one wide orifice.
Broader Impacts:
Throughout the course of this project, the principal impact to society has been the training and development of multiple young scientists. Notably, two doctoral students completed their PHD dissertations as a direct result of this project. In addition, twelve undergraduate students have taken part in multiple semesters of research, received training in good scientific practice, and have co-authored peer-reviewed scientific articles. Multiple scientific papers have been published and conference presentations have been made to disseminate the results of the work to a broad scientific audience. Aside from the development of personnel in science, our findings have the scope to improve needle-free drug delivery, especially for novel vaccines and therapeutic drugs.
Last Modified: 09/10/2024
Modified by: Jeremy O Marston
Please report errors in award information by writing to: awardsearch@nsf.gov.